Cargando…
Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) overexpression in tumors predicts worse overall survival in hepatocellular carcinoma
Overexpression of AKR1B10 correlated with tumorigenesis of many human malignancies; however, the prognostic value of AKR1B10 expression in patients with hepatocellular carcinoma (HCC) still remains controversial. In this analysis, AKR1B10 expression in HCC tumors were evaluated in GEO, TCGA and Onco...
Autores principales: | Shi, Jia, Chen, Lixiang, Chen, Yi, Lu, Yunfei, Chen, Xiaorong, Yang, Zongguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775506/ https://www.ncbi.nlm.nih.gov/pubmed/31598161 http://dx.doi.org/10.7150/jca.32768 |
Ejemplares similares
-
Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma
por: Chung, Yeon Tae, et al.
Publicado: (2012) -
Immunohistochemistry Detects Increased Expression of Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) in Early-Stage Hepatocellular Carcinoma
por: Han, Chao, et al.
Publicado: (2018) -
Prognostic value of aldo-keto reductase family 1 member B10 (AKR1B10) in digestive system cancers: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2021) -
Aldo-keto reductase (AKR) superfamily: Genomics and annotation
por: Mindnich, Rebekka D, et al.
Publicado: (2009) -
Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression
por: Robinson, Kathy, et al.
Publicado: (2023)